Dr. Urrutia reviews the methodology and main findings of 2018 review on FABM effectiveness for avoiding pregnancy and disucsses the important limitations of the data including population-based differences in effectiveness, especially among breastfeeding and postpartum individuals. She also introduces and identifies clinical decision-making tools providers and patients regarding choosing an FABM to avoid pregnancy, reviews new technologies currently being applied to FABM use, and discusses the role of the FDA in clearing fertility awareness apps for contraception.
Danielle Koestner, MD presents the practical application and use of the Fertility Education and Medical Management (FEMM) app in clinical practice, followed by a discussion. FEMM is an app and fertility management tool that is free to download, and teaches women how to monitor hormonal activity and identify ovulation, to manage both health and fertility.
Dr. Whittaker reviews the success rates and limitations of ART and the treatments offered by the NaProTechnology (a version of restorative reproductive medicine) as well as its limitations. Develop an understanding of both approaches and better understand the impact on a societal level of ART.
Dr. Carpentier shares his experience with and looks into the science behind the use of dexamphetamine treatment as a novel off-label treatment for a number of female chronic disorders that do not respond well to conventional therapy including recurrent pregnancy loss, inflammation, and ongoing pain. The primary article of focus for this journal club, “The neurotransmitter dopamine modulates vascular permeability in the endothelium”, along with a list of references can be downloaded to accompany the webinar.
What is the association between the gut microbiome and PCOS? What about the impact of the microbiome on health and diseases? Dr. April Lind explores the potential relationship between the gut microbiome and PCO, as well as providing an overall understanding of what exactly is meant by the microbiome and the effect on health and disease. Learn new ways of optimizing treatment for PCO, and share your thoughts on potential options for better treatment and management of this disease in the forum.
This webinar explores the science, safety, and clinical application of botanical medicine (herbal medicine) options for reproductive health and in supporting hormonal balance. Treatment and support for common reproductive conditions such as PCOS, estrogen dominance, elevated androgens, thyroid support and ovarian reserve support. Dr. BreAnna Guan also covers botanical formulas for safety and clinical effectiveness as well as safety and herb/drug interaction in reproductive medicine.
RRM Research Updates this April looks at shared decision making (SDM), the use of a tool in this process, and preliminary results of a study of an SDM tool designed to assist women to choose an appropriate FABM (Fertility awareness-based Method). Look at other research Dr. Marguerite Duane and her team at FACTS are working on, and learn where the priorities are in the area of fertility awareness education.
Celebrate 20 years of bringing together a community of medical professionals and supporters who are helping to transform reproductive medicine at the 2020 International RRM Virtual Conference. Hear the latest developments, innovations, and research in the area of RRM. Listen to our Fireside Chat in which 6 clinical cases of PCOS were presented, with each presentation highlighting a different science-based method of charting that assists in identifying, managing, and treating a patient with PCOS.
Dr. Kongoassa, Medical Director, and Restorative Reproductive Surgeon, at the Centre for Reproductive Health Medicine and Gynecology, and the Center for Restorative Reproductive Surgery, runs through the diagnosis of abnormal physiology and pathology as well as different surgical approaches to restoring and optimizing reproductive function. With extensive video, this 1-hour presentation outlines the identification, and surgical options for a number of conditions including endometriosis, adenomyosis, fallopian tube blockages/damage, fibroids, uterine polyps, low ovarian reserve, isthmocele, chronic endometritis, and ovarian cysts.